A double-blind, placebo-controlled cross-over trial published in BMC Gastroenterology evaluated whether 12 g/day of chicory inulin improves bowel habits, patient-reported outcomes, and gut microbiota...
In a randomized controlled trial of adults with Rome IV irritable bowel syndrome without constipation, investigators found that a Mediterranean-style low-FODMAP diet produced greater symptom improvement,...
A randomized, double-blind trial evaluated whether 4 commonly used nutritional supplements could improve symptoms or microbiota-related outcomes in adults with irritable bowel syndrome.
A post hoc analysis of the ProDeCa randomized trial found that a four-strain psychobiotic regimen added to standard analgesia reduced multidimensional pain scores in postoperative gastrointestinal cancer...
Recent research found that soft drink consumption may be linked to major depressive disorder diagnosis and increased depressive symptom severity, with significant associations observed only among women.
...
In a phase 3 trial, trastuzumab deruxtecan significantly extended overall survival compared with ramucirumab plus paclitaxel in previously treated patients, with manageable toxicity and mostly low-grade...
Postdischarge ondansetron cut the risk of moderate-to-severe gastroenteritis in children by half, without increasing adverse events or health care use.
A large randomized trial found that mailing unsolicited fecal immunochemical test kits increased colorectal cancer screening rates among adults aged 45 to 49 compared with strategies requiring patients to...
A retrospective cohort study found that patients undergoing outpatient GI procedures who received opioids intra- or post-operatively reported lower pain scores and fewer instances of postoperative nausea...
A new study finds that oral fecal microbiota transplantation (FMT) capsules combined with partial enteral nutrition are as effective as immunosuppressants in treating pediatric Crohn disease. The treatment...
